Purpose of Review

This review highlights indications and evidence on laser therapy in the management of diabetic retinopathy and diabetic macular edema. Particular focus is placed upon the benefits and limitations of conventional laser photocoagulation versus more modern laser photocoagulation techniques, as well as the role of laser photocoagulation in treatment of diabetic retinopathy and diabetic macular edema with the frequent utilization of pharmacologic, including anti-vascular endothelial growth factor (VEGF), therapy.

Recent Findings

Laser photocoagulation remains the gold-standard therapy for the effective, definitive treatment of PDR, and also is highly effective in the management of DME. However, numerous recent studies have demonstrated the clinical efficacy and improved functional and anatomic outcomes of combination therapy with pharmacologic treatment.

Summary

Continuing innovations in laser technology and improved understanding of laser-retinal interactions and pathophysiology demonstrate that laser therapy will continue to play a critical role in the treatment of diabetic retinopathy and diabetic macular edema for many years to come.

中文翻译：

---

激光治疗糖尿病性视网膜病变和糖尿病性黄斑水肿

审查目的

这篇综述强调了激光疗法在治疗糖尿病性视网膜病变和糖尿病性黄斑水肿中的适应症和证据。特别关注传统激光光凝术与更现代的激光光凝术技术的优势和局限性，以及激光光凝术在治疗糖尿病性视网膜病变和糖尿病性黄斑水肿中的作用，经常使用药物，包括抗血管内皮生长因子（VEGF），治疗。

最近的发现

激光光凝术仍然是有效、明确治疗 PDR 的金标准疗法，并且在 DME 的管理中也非常有效。然而，许多最近的研究已经证明了联合治疗与药物治疗的临床疗效和改善的功能和解剖学结果。

概括

激光技术的持续创新以及对激光-视网膜相互作用和病理生理学的深入了解表明，激光治疗在未来许多年内将继续在糖尿病性视网膜病变和糖尿病性黄斑水肿的治疗中发挥关键作用。